Bio-Technology General Euflexxa 1% Sodium Hyaluronate

Страна: Сінгапур

мова: англійська

Джерело: HSA (Health Sciences Authority)

Доступна з:

FERRING PHARMACEUTICALS PRIVATE LIMITED

Клас:

Class D medical device

Виробник:

Bio-Technology General (Israel) Ltd.

Терапевтична области:

Orthopaedics

Терапевтичні свідчення:

EUFLEXXA is indicated for the treatment of pain caused by osteoarthritis of the knee, hip, temporomandibular, carpometacarpal, shoulder and ankle joints. EUFLEXXA aids in lubrication of the joint, allows for greater mobility and flexibility of the treated joint, and reduces pain in the affected joint.

Огляд продуктів:

Device System Info:[Sterile Medical Device], EUFLEXXA is packed in a single-use, aseptically-filled disposable sterile 2.25 ml syringe (nominal volume) containing either 1 ml or 2 ml of 1% microbial fermentation-derived NaHA in phosphate-buffered saline; Models: Euflexxa 1% Sodium Hyaluronate - 3 x 2ml, Euflexxa 1% Sodium Hyaluronate - 1 x 2ml

Дата Авторизація:

2017-04-28